Clinical Trial: Safety and Efficacy Assessment of HAV (Manufactured Using Large-scale System) in Patients Needing Vascular Access for Dialysis

U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT04135417) titled 'Safety and Efficacy Assessment of HAV (Manufactured Using Large-scale System) in Patients Needing Vascular Access for Dialysis' on Oct. 16.

Brief Summary: This is a Phase 2, prospective, multicenter, open-label, single-arm study of the Human Acellular Vessel (HAV).

Study Type: Interventional

Condition: * Renal Failure

* End Stage Renal Disease

* Vascular Access

* Hemodialysis

Intervention: Biological: HAV

Surgical implantation of the HAV and subsequent use of the implanted vascular conduit for hemodialysis vascular access.

Recruitment Status: Not Yet Recruiting

Sponsor: Humacyte, Inc.

Information provided by (Responsible P...